Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M6,467Revenue $M--Net Margin (%)--Altman Z-Score
Enterprise Value $M6,467EPS $--Operating Margin %--Piotroski F-Score--
P/E(ttm)19.7Beneish M-Score--Pre-tax Margin (%)--Higher ROA y-yN
Price/Book4.510-y EBITDA Growth Rate %--Quick Ratio--Cash flow > EarningsN
Price/Sales--5-y EBITDA Growth Rate %--Current Ratio--Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)--Higher Current Ratio y-yN
Dividend Yield %0.1PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M24,950,000ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with IBB

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
IBBJohn Keeley 2015-09-30 Sold Out -0.01%$289.48 - $398
($359.64)
$ 259.19-28%Sold Out0
IBBGeorge Soros 2015-09-30 Sold Out -0.01%$289.48 - $398
($359.64)
$ 259.19-28%Sold Out0
IBBGeorge Soros 2015-06-30 Buy 0.01%$333.61 - $383.19
($358.63)
$ 259.19-28%New holding2,400
IBBJohn Keeley 2014-12-31 Buy 0.01%$255.27 - $308.01
($283.24)
$ 259.19-8%New holding905
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

IBB is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


IBB: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Dubuc, PhilippeSenior Officer 2016-04-08Buy1,700$1.9912866.33view
Dubuc, PhilippeSenior Officer 2016-04-08Buy3,300$212801.5view
PAMPLIN, Ann-Marie MichelleDeemed Insider - 6 Months before becoming Insider 2016-04-08Buy10,000$0.15171920view
Williams, Allan WilliamSenior Officer 2016-04-08Buy108,500$0.11234472.73view
Stefura, Naomi MarieSenior Officer 2016-04-08Sell4,200$14.61667.33view
Gentiletti, NelsonDirector or Senior Officer of Insider or Subsidiar 2016-04-08Sell800$20.781141.72view
Gentiletti, NelsonDirector or Senior Officer of Insider or Subsidiar 2016-04-08Sell400$20.771142.32view
Gentiletti, NelsonDirector or Senior Officer of Insider or Subsidiar 2016-04-08Sell300$20.751143.52view
Gentiletti, NelsonDirector or Senior Officer of Insider or Subsidiar 2016-04-08Sell100$20.721145.32view
Gentiletti, NelsonDirector or Senior Officer of Insider or Subsidiar 2016-04-08Sell900$20.71146.52view

Press Releases about IBB :

Quarterly/Annual Reports about IBB:

    News about IBB:

    Articles On GuruFocus.com
    Investment Strategies for the Bullish Biotech Sector Jun 01 2015 

    More From Other Websites
    Relypsa Taps Debt Market: Yeah, That’s Bullish May 03 2016
    Investing in biotech May 03 2016
    Adam Feuerstein On Biotechs: 'I Have An Itchy Trigger Finger On Hypocrisy' May 02 2016
    Biotech ETFs Sink on Mixed Q1 Results May 02 2016
    Top Trades: Biotech's brutal week Apr 29 2016
    5 way to trade the mixed biotech sector Apr 29 2016
    Pisani: Beware complacency! Apr 29 2016
    Big health care deals Apr 28 2016
    Drug pricing debate: Fred Hassan Apr 26 2016
    I'm a 'fan' of Joe's: Fred Hassan Apr 26 2016
    Seattle Genetics’ Profitability: What’s Expected in 1Q16? Apr 25 2016
    Lightning round: trading this week's earnings Apr 25 2016
    Closing Bell Exchange: Busy week for earnings, central ba... Apr 25 2016
    Healthcare ETFs Face Election Year Blues Apr 25 2016
    Why Relypsa Spiked Today and a Letter to the CEO Apr 21 2016
    Why It May Be Time to Get Bullish on Biotech Apr 20 2016
    Seattle Genetics: Why Are Its 1Q16 Revenues Expected to Grow? Apr 20 2016
    Why you shouldn’t let oil crush your stock hopes Apr 20 2016
    2016 Investment Landscape: Right Sector at the Right Time Apr 19 2016
    Wall Street is Dead Wrong: Why It's Time to Buy Illumina Apr 19 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)